However, given the change in HER2 status from the primary breast neoplasm to the brain metastasis that occurs in approximately 10%–15% of cases, a biopsy or resection of the breast cancer brain metastasis is currently the only way to definitively establish the HER2 status of the breast cancer brain metastasis. The gene discussed is ERBB2; the disease is breast neoplasm.